Logo image of SNW.DE

SANOFI (SNW.DE) Stock Fundamental Analysis

FRA:SNW - FR0000120578 - Common Stock

79.16 EUR
-0.34 (-0.43%)
Last: 9/8/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, SNW scores 6 out of 10 in our fundamental rating. SNW was compared to 50 industry peers in the Pharmaceuticals industry. SNW has an excellent profitability rating, but there are some minor concerns on its financial health. SNW has a correct valuation and a medium growth rate. Finally SNW also has an excellent dividend rating. These ratings would make SNW suitable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SNW had positive earnings in the past year.
In the past year SNW had a positive cash flow from operations.
In the past 5 years SNW has always been profitable.
Each year in the past 5 years SNW had a positive operating cash flow.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

With a decent Return On Assets value of 11.05%, SNW is doing good in the industry, outperforming 78.00% of the companies in the same industry.
SNW's Return On Equity of 19.73% is fine compared to the rest of the industry. SNW outperforms 70.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.84%, SNW is in the better half of the industry, outperforming 74.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SNW is significantly below the industry average of 14.78%.
The last Return On Invested Capital (13.84%) for SNW is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 20.35%, SNW is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SNW has grown nicely.
SNW has a Operating Margin of 23.59%. This is in the better half of the industry: SNW outperforms 62.00% of its industry peers.
SNW's Operating Margin has improved in the last couple of years.
SNW's Gross Margin of 71.70% is in line compared to the rest of the industry. SNW outperforms 58.00% of its industry peers.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNW is creating value.
The number of shares outstanding for SNW remains at a similar level compared to 1 year ago.
SNW has about the same amout of shares outstanding than it did 5 years ago.
SNW has a better debt/assets ratio than last year.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

SNW has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNW would need 2.21 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.21, SNW belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SNW has a Debt to Equity ratio of 0.21. This is in the better half of the industry: SNW outperforms 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.86
WACC7.43%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.27 indicates that SNW should not have too much problems paying its short term obligations.
SNW has a Current ratio (1.27) which is comparable to the rest of the industry.
SNW has a Quick Ratio of 1.27. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.94, SNW is in line with its industry, outperforming 52.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

SNW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.20%.
Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 6.45% in the past year.
SNW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%

3.2 Future

SNW is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.41% yearly.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue Next Year0.18%
Revenue Next 2Y3.45%
Revenue Next 3Y4.32%
Revenue Next 5Y4.04%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.48, the valuation of SNW can be described as reasonable.
82.00% of the companies in the same industry are more expensive than SNW, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.07, SNW is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.08, the valuation of SNW can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SNW is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.59. SNW is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.48
Fwd PE 9.08
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SNW's Enterprise Value to EBITDA is on the same level as the industry average.
SNW's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNW is cheaper than 64.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.17
EV/EBITDA 10.2
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNW does not grow enough to justify the current Price/Earnings ratio.
SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.68
PEG (5Y)2.06
EPS Next 2Y6.53%
EPS Next 3Y6.33%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.96%, SNW is a good candidate for dividend investing.
SNW's Dividend Yield is rather good when compared to the industry average which is at 3.06. SNW pays more dividend than 86.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, SNW pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SNW pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SNW.DE Dividend Payout.SNW.DE Dividend Payout, showing the Payout Ratio.SNW.DE Dividend Payout.PayoutRetained Earnings

SANOFI

FRA:SNW (9/8/2025, 7:00:00 PM)

79.16

-0.34 (-0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-24 2025-10-24/bmo
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap193.07B
Analysts80
Price Target109.78 (38.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-1.83%
PT rev (3m)-8.01%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)-4.12%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 10.48
Fwd PE 9.08
P/S 2.84
P/FCF 19.17
P/OCF 16.97
P/B 2.76
P/tB 20.77
EV/EBITDA 10.2
EPS(TTM)7.55
EY9.54%
EPS(NY)8.72
Fwd EY11.01%
FCF(TTM)4.13
FCFY5.22%
OCF(TTM)4.67
OCFY5.89%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.68
PEG (5Y)2.06
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.43%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year0.18%
Revenue Next 2Y3.45%
Revenue Next 3Y4.32%
Revenue Next 5Y4.04%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y9.88%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%